ERNA logo

Eterna Therapeutics (ERNA)

Profile

Full Name

Ernexa Therapeutics Inc.

Ticker Symbol

ERNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 29, 1991

Indexes

Not included

Website

http://eternatx.com

Employees

6

Key Details

Price

$0.21(+9.79%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$582.00K(+755.88% YoY)

Annual EPS

-$3.26(+20.10% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.21
ERNA price is $0.21

30-Day Relative Volume

0.56
ERNA 30-day relative volume is 0.56

Price Performance

Price Most recent change

+9.79%
ERNA price was up +9.79% on Apr 14, 2025

Price YTD change

-28.07%
ERNA price is down -28.07% since January 1st

Price 1-year change

-90.69%
ERNA price is down -90.69% year-on-year

Price 3-year change

-99.36%
ERNA price is down -99.36% over the past 3 years

Price Range

Price All-time high

$23000.00
ERNA price is currently -100.00% below its historical high of $23000.00

Price 3-year low

$0.15
ERNA price is currently +39.07% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$10.90M
ERNA market capitalization is $10.90 million

Market cap 3-year change

-88.43%
ERNA market capitalization is down -88.43% over the past 3 years

Market cap All-time high

$3.26B
ERNA market capitalization is currently -99.67% below its historical high of $3.26 billion

Market cap sector rank

20.87%
ERNA market capitalization is higher than 20.87% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+865.66%
ERNA shares outstanding is up +865.66% year-on-year

Shares Outstanding 3-Year Change

+1718.73%
ERNA shares outstanding is up +1718.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.25
ERNA beta is 1.25

200-day SMA

$0.90
ERNA price is currently -76.91% below its 200-day simple moving average

50-day SMA

$0.26
ERNA price is currently -21.22% below its 50-day simple moving average

RSI

40.98
ERNA 14-day relative strength index is 40.98

Volume

0.56
ERNA 30-day relative volume is 0.56

ATR

$0.03
ERNA average true range is $0.03

10-day Historical Volatility

122.86%
ERNA 10-day historical volatility is 122.86%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$582.00K
ERNA annual revenue is $582.00 thousand

Revenue Analysts estimate

-
ERNA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+755.88%
ERNA annual revenue is up +755.88% year-on-year

Revenue Sector rank

10.53%
ERNA annual revenue is higher than 10.53% of companies in Healthcare sector

EPS

EPS

-$3.26
ERNA annual earnings per share is -$3.26

EPS Analysts estimate

-
ERNA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+20.1%
ERNA annual earnings per share is up +20.1% year-on-year

EPS Sector rank

27.46%
ERNA annual earnings per share is higher than 27.46% of companies in Healthcare sector

Profit

Gross profit

$486.00K
ERNA annual gross profit is $486.00 thousand

Gross margin

83.51%
ERNA annual gross profit margin is 83.51%

Operating profit

-$17.25M
ERNA annual operating income is -$17.25 million

Operating margin

-2963.92%
ERNA annual operating profit margin is -2963.92%

Net income

-$44.54M
ERNA annual net profit is -$44.54 million

Net margin

-7652.75%
ERNA annual net profit margin is -7652.75%

Expenses

Total expenses

$17.83M
ERNA annual total expenses is $17.83 million

Operating expenses

$17.74M
ERNA annual total operating expenses is $17.74 million

Cost of goods sold

$96.00K
ERNA annual cost of goods sold is $96.00 thousand

Selling, general & administrative expenses

$13.13M
ERNA annual SGA is $13.13 million

Depreciation and amortization

$1.64M
ERNA annual depreciation & amortization is $1.64 million

Interest expense

$6.75M
ERNA annual interest expense is $6.75 million

Income tax

$30.00K
ERNA annual income tax is $30.00 thousand

EBIT & EBITDA

EBIT

-$37.76M
ERNA annual earnings before interest & taxes is -$37.76 million

EBITDA

-$36.12M
ERNA annual EBITDA is -$36.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.27M
ERNA annual total assets is $5.27 million

Non current assets

$2.92M
ERNA annual long term assets is $2.92 million

Current assets

$2.35M
ERNA annual total current assets is $2.35 million

Cash and cash equivalents

$1.73M
ERNA annual cash & cash equivalents is $1.73 million

Accounts receivable

-
ERNA annual accounts receivable value is unknown

Inventory

-
ERNA annual inventory value is unknown

Liabilities

Total liabilities

$3.57M
ERNA annual total liabilities is $3.57 million

Long term liabilities

$630.00K
ERNA annual total long term liabilities is $630.00 thousand

Current liabilities

$2.94M
ERNA annual total current liabilities is $2.94 million

Accounts payable

$1.72M
ERNA annual accounts payable is $1.72 million

Debt

Total debt

$684.00K
ERNA annual total debt is $684.00 thousand

Total debt 1-year change

-98.37%
ERNA annual total debt is down -98.37% year-on-year

Long term debt

$477.00K
ERNA annual long term debt is $477.00 thousand

Short term debt

$207.00K
ERNA annual short term debt is $207.00 thousand

Equity & Capital

Shareholders equity

$1.70M
ERNA annual stockholders equity is $1.70 million

Book value

$1.70M
ERNA annual book value is $1.70 million

Retained earnings

-$231.54M
ERNA annual retained earnings is -$231.54 million

Working capital

-$586.00K
ERNA annual working capital is -$586.00 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.84M
ERNA annual cash flow from operations is -$15.84 million

Cash from operations 1-year change

+22.4%
ERNA annual cash flow from operations is up +22.4% year-on-year

Cash from investing

-$365.00K
ERNA annual cash flow from investing activities is -$365.00 thousand

Cash from investing 1-year change

-1821.05%
ERNA annual cash flow from investing activities is down -1821.05% year-on-year

Cash from financing

$6.26M
ERNA annual cash flow from financing activities is $6.26 million

Cash from financing 1-year change

-62.19%
ERNA annual cash flow from financing activities is down -62.19% year-on-year

CAPEX

CAPEX

$369.00K
ERNA annual capital expenditures is $369.00 thousand

CAPEX 1-year change

+1842.11%
ERNA annual capital expenditures is up +1842.11% year-on-year

Free Cash Flow

Free cash flow

-$16.20M
ERNA annual free cash flow is -$16.20 million

Free cash flow 1-year change

+20.67%
ERNA annual free cash flow is up +20.67% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

83.51%
ERNA annual gross profit margin is 83.51%

Operating margin

-2963.92%
ERNA annual operating profit margin is -2963.92%

Net margin

-7652.75%
ERNA annual net profit margin is -7652.75%

ROA & ROE

ROA

-163.74%
ERNA annual return on assets is -163.74%

ROE

-2264.31%
ERNA annual return on equity is -2264.31%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ERNA price to earnings ratio value is unknown

PE ratio Sector rank

-
ERNA price to earnings ratio is unknown

PB Ratio

PB ratio

6.41
ERNA price to book ratio is 6.41

PB ratio Sector rank

87.09%
ERNA price to book ratio is higher than 87.09% of companies in Healthcare sector

PS Ratio

PS ratio

18.73
ERNA price to sales ratio is 18.73

PS ratio Sector rank

86.15%
ERNA price to sales ratio is higher than 86.15% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.85M
ERNA enterprise value is $9.85 million

Enterprise value Sector rank

24.69%
ERNA enterprise value is higher than 24.69% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.27
ERNA EV/EBITDA is -0.27

EV/EBITDA Sector rank

56.73%
ERNA EV/EBITDA is higher than 56.73% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.80
ERNA annual current ratio is 0.80

Quick ratio

-
ERNA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ERNA annual debt to equity ratio is 0.00

Interest coverage ratio

-5.59
ERNA annual interest coverage ratio is -5.59

Risk & Stability

Piotroski F-Score

-
ERNA piotroski f-score value is unknown

Altman Z-Score

-83.36
ERNA altman z-score is -83.36

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

PSTV logo
Plus Therapeutics (PSTV)
HOTH logo
Hoth Therapeutics (HOTH)
NERV logo
Minerva Neurosciences (NERV)
MBRX logo
Moleculin Biotech (MBRX)
BLRX logo
BioLineRx (BLRX)
TLPH logo
Talphera (TLPH)
TRAW logo
Traws Pharma (TRAW)
TRIB logo
Trinity Biotech (TRIB)
PETV logo
PetVivo Holdings (PETV)
  • What is the ticker symbol for Eterna Therapeutics?
  • Does Eterna Therapeutics pay dividends?
  • What sector is Eterna Therapeutics in?
  • What industry is Eterna Therapeutics in?
  • What country is Eterna Therapeutics based in?
  • When did Eterna Therapeutics go public?
  • Is Eterna Therapeutics in the S&P 500?
  • Is Eterna Therapeutics in the NASDAQ 100?
  • Is Eterna Therapeutics in the Dow Jones?
  • When was Eterna Therapeutics's last earnings report?
  • When does Eterna Therapeutics report earnings?
  • Should I buy Eterna Therapeutics stock now?

What is the ticker symbol for Eterna Therapeutics?

The ticker symbol for Eterna Therapeutics is NASDAQ:ERNA

Does Eterna Therapeutics pay dividends?

No, Eterna Therapeutics does not pay dividends

What sector is Eterna Therapeutics in?

Eterna Therapeutics is in the Healthcare sector

What industry is Eterna Therapeutics in?

Eterna Therapeutics is in the Biotechnology industry

What country is Eterna Therapeutics based in?

Eterna Therapeutics is headquartered in United States

When did Eterna Therapeutics go public?

Eterna Therapeutics's initial public offering (IPO) was on August 29, 1991

Is Eterna Therapeutics in the S&P 500?

No, Eterna Therapeutics is not included in the S&P 500 index

Is Eterna Therapeutics in the NASDAQ 100?

No, Eterna Therapeutics is not included in the NASDAQ 100 index

Is Eterna Therapeutics in the Dow Jones?

No, Eterna Therapeutics is not included in the Dow Jones index

When was Eterna Therapeutics's last earnings report?

Eterna Therapeutics's most recent earnings report was on Nov 12, 2024

When does Eterna Therapeutics report earnings?

The next expected earnings date for Eterna Therapeutics is May 14, 2025

Should I buy Eterna Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page